Generate a tailored SOP for Dr. Mark Reed. Improve your application with a focused, well-structured draft.
Mark Reed is a medicinal chemist and Staff Scientist at the Krembil Research Institute, University Health Network (UHN). In 2018, he established the Centre for Medicinal Chemistry Drug Discovery (CMCDD) to aid academic researchers in translating discoveries into druggable targets. This facility provides medicinal chemistry support for probe synthesis, hit identification strategies, lead optimization, and molecular modeling to develop small molecule therapeutics that can be commercialized into meaningful treatments for diseases. Mark has 20 years of industrial experience in drug discovery, working with startups like Treventis Corporation in Toronto, biotech firms such as ICOS Corporation in Seattle, and large pharmaceutical companies including Schering Plough Research Institute in Cambridge, MA. He has implemented modern medicinal chemistry practices focused on identifying and advancing de-risked lead compounds in areas like CNS disorders, anti-infectives, immunology, and oncology. Mark Reed has published numerous papers and patents in the fields of synthetic organic chemistry, neurodegeneration, neuropathic pain, and inflammation.
Department of Sociology